Jasper Therapeutics Inc.-CW26JSPRWPreferred / convertible
13F holders, Q2 2024 (June 30)5holders +1
1new positions
0sold out
$0.20avg. 13F price*
At the end of Q2 2024, 5 institutions reported holding Jasper Therapeutics Inc.-CW26 (JSPRW) in their 13F filings, up 1 from Q1 2024. 1 opened new positions and 0 sold out. The largest holders were Cowen and Company, LLC ($434K), Walleye Capital LLC ($119K) and TENOR CAPITAL MANAGEMENT Co., L.P. ($50K).
- Company
- Jasper Therapeutics Inc.-CW26
- CUSIP
- 471871111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $13K |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 137,581 shares bought, net +137,581 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Cowen and Company, LLC | — | Add +3.4% | 2,170,749 | $434K |
| Walleye Capital LLC | — | No change | 596,014 | $119K |
| TENOR CAPITAL MANAGEMENT Co., L.P. | — | No change | 250,000 | $50K |
| Zazove Associates LLC | — | New | 65,456 | $13K |
| Walleye Trading LLC | — | No change | 14,095 | $3K |
"% of holder's portfolio" is JSPRW's weight in each manager's 13F, not the share of Jasper Therapeutics Inc.-CW26 the manager owns.